skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia

Review

(1952) Views  (2166) Full article downloads

Authors: Ayman A Hussein, Stephen J Nicholls

Published Date April 2010 Volume 2010:6 Pages 183 - 190
DOI: http://dx.doi.org/10.2147/TCRM.S7306

Ayman A Hussein, Stephen J Nicholls

Cardiovascular Medicine Department, Cleveland Clinic Foundation, Cleveland, OH, USA

Abstract: Niacin is a B-complex vitamin which has been used for decades for the management of mixed dyslipidemias and primary hypercholesterolemia. It decreases the risk of cardiovascular events either when used as a monotherapy or in combination with other lipid lowering medications. However, a major limitation to its use is niacin-induced flushing occurring even with the extended-release formulations. Laropiprant, a selective prostaglandin-2 receptor inhibitor, specifically targets the cascade of events causing the flushing. It has been recently used in combination with extended-release niacin. This article will review the early experience with this combination with focus on efficacy, safety, tolerability and current place in therapy. Early data are promising and suggest that more patients in clinical practice will benefit from niacin combined with laropiprant. Ongoing clinical trials will provide a better insight on the long-term safety of the drug and its efficacy for reducing cardiovascular events.

Keywords: niacin, laropiprant, dyslipidemias, hypercholesterolemia








Readers of this article also read:

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
Critical appraisal and clinical utility of atosiban in the management of preterm labor
Succession planning for advanced nursing practice; contingency or continuity? The Scottish experience
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
The influence of locus control on adherence to treatment regimen among hypertensive patients
Differences in taste between three polyethylene glycol preparations: a randomized double-blind study
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy